Net Cash Provided by (Used in) Financing Activities in USD of CANNAPHARMARX, INC. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CANNAPHARMARX, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2010 to Q1 2025.
  • CANNAPHARMARX, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $600K, a 7.17% increase year-over-year.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1.7M, a 27.8% decline from 2023.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.35M, a 67.5% increase from 2022.
  • CANNAPHARMARX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.4M, a 4.79% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CANNAPHARMARX, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $600K +$40.2K +7.17% 01 Jan 2025 31 Mar 2025 10-Q 16 May 2025
Q1 2024 $560K +$67K +13.6% 01 Jan 2024 31 Mar 2024 10-Q 16 May 2025
Q1 2023 $493K -$23K -4.45% 01 Jan 2023 31 Mar 2023 10-Q 25 Jun 2024
Q1 2022 $516K +$19.5K +3.93% 01 Jan 2022 31 Mar 2022 10-Q 22 Sep 2023
Q1 2021 $497K +$154K +44.8% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q1 2020 $343K +$264K +334% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q1 2019 $79K +$79K 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q1 2018 $0 $0 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $0 -$19.8K -100% 01 Jan 2017 31 Mar 2017 10-Q 14 Sep 2018
Q1 2016 $19.8K -$435K -95.7% 01 Jan 2016 31 Mar 2016 10-Q 14 Sep 2018
Q1 2015 $455K +$448K +7416% 01 Jan 2015 31 Mar 2015 10-Q 14 Sep 2018
Q1 2014 $6.05K +$647 +12% 01 Jan 2014 31 Mar 2014 10-Q 19 May 2014
Q1 2013 $5.4K -$200 -3.57% 01 Jan 2013 31 Mar 2013 10-Q 19 May 2014
Q1 2012 $5.6K -$9.4K -62.7% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q1 2011 $15K $0 0% 01 Jan 2011 31 Mar 2011 10-Q 01 Jul 2011
Q1 2010 $15K 01 Jan 2010 31 Mar 2010 10-Q 01 Jul 2011

CANNAPHARMARX, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.7M -$655K -27.8% 01 Jan 2024 31 Dec 2024 10-K 10 Apr 2025
2023 $2.35M +$949K +67.5% 01 Jan 2023 31 Dec 2023 10-K 10 Apr 2025
2022 $1.4M +$64.2K +4.79% 01 Jan 2022 31 Dec 2022 10-K 01 Sep 2023
2021 $1.34M +$516K +62.6% 01 Jan 2021 31 Dec 2021 10-K 01 Sep 2023
2020 $825K -$2.44M -74.8% 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022
2019 $3.27M +$1.13M +53.2% 01 Jan 2019 31 Dec 2019 10-K 14 Apr 2021
2018 $2.13M +$2.13M 01 Jan 2018 31 Dec 2018 10-K 27 May 2020
2017 $0 -$19.8K -100% 01 Jan 2017 31 Dec 2017 10-K 03 Apr 2019
2016 $19.8K -$791K -97.6% 01 Jan 2016 31 Dec 2016 10-K 14 Sep 2018
2015 $810K -$2.49M -75.4% 01 Jan 2015 31 Dec 2015 10-K 14 Sep 2018
2014 $3.3M 01 Jan 2014 31 Dec 2014 10-K 11 Sep 2018
2012 $10.9K -$1.12K -9.28% 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2013
2011 $12K -$48K -80% 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013
2010 $60K 01 Jan 2010 31 Dec 2010 10-K/A 30 Jun 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.